Research Temps Hired at a Premium

WASHINGTON—James Welty is a professor of mechanical engineering at Oregon State University. But for the past 16 months he has been living on the East Coast under a special program that brings academics temporarily into government service. Welty works at the Department of Energy, reviewing grant proposals, setting up engineering meetings, and advising other scientists. He is one of 970 researchers currently on detail to the federal government under the Intergovernmental Personnel Act, whic

Written byRobert Rothman
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Welty works at the Department of Energy, reviewing grant proposals, setting up engineering meetings, and advising other scientists. He is one of 970 researchers currently on detail to the federal government under the Intergovernmental Personnel Act, which allows agencies to hire university faculty for a short time at salaries higher than they could earn as civil servants.

The federal agencies gain access to top-flight researchers who are familiar with the most recent developments in their fields. Such professors are often reluctant to come to Washington, government officials say, because of the government's restrictive salary schedule.

Researchers, in turn, enjoy a firsthand look at the federal agencies that fund their work. They expect such experience to serve them and their institutions well when they return.

The program, begun in 1970, has recently come under fire from some members of Congress. Sen. William Proxmire (D-Wis.), chairman of the Senate Appropriations subcommittee that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies